Pediatrics. 2011 Sep;128(3):595-610. doi: 10.1542/peds.2011-1330. Epub 2011 Aug 28.
To revise the American Academy of Pediatrics practice parameter regarding the diagnosis and management of initial urinary tract infections (UTIs) in febrile infants and young children.
Analysis of the medical literature published since the last version of the guideline was supplemented by analysis of data provided by authors of recent publications. The strength of evidence supporting each recommendation and the strength of the recommendation were assessed and graded.
Diagnosis is made on the basis of the presence of both pyuria and at least 50,000 colonies per mL of a single uropathogenic organism in an appropriately collected specimen of urine. After 7 to 14 days of antimicrobial treatment, close clinical follow-up monitoring should be maintained to permit prompt diagnosis and treatment of recurrent infections. Ultrasonography of the kidneys and bladder should be performed to detect anatomic abnormalities. Data from the most recent 6 studies do not support the use of antimicrobial prophylaxis to prevent febrile recurrent UTI in infants without vesicoureteral reflux (VUR) or with grade I to IV VUR. Therefore, a voiding cystourethrography (VCUG) is not recommended routinely after the first UTI; VCUG is indicated if renal and bladder ultrasonography reveals hydronephrosis, scarring, or other findings that would suggest either high-grade VUR or obstructive uropathy and in other atypical or complex clinical circumstances. VCUG should also be performed if there is a recurrence of a febrile UTI. The recommendations in this guideline do not indicate an exclusive course of treatment or serve as a standard of care; variations may be appropriate. Recommendations about antimicrobial prophylaxis and implications for performance of VCUG are based on currently available evidence. As with all American Academy of Pediatrics clinical guidelines, the recommendations will be reviewed routinely and incorporate new evidence, such as data from the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study.
Changes in this revision include criteria for the diagnosis of UTI and recommendations for imaging.
修订美国儿科学会关于发热婴儿和幼儿初始尿路感染(UTI)的诊断和管理的实践参数。
对自上次指南版本发布以来发表的医学文献进行分析,并辅以对近期出版物作者提供的数据进行分析。评估并分级支持每项建议的证据强度和推荐强度。
根据适当采集的尿液标本中存在脓尿和单一尿路致病微生物每毫升至少 50,000 个菌落这两个条件来做出诊断。在接受 7 至 14 天的抗菌治疗后,应进行密切的临床随访监测,以允许及时诊断和治疗反复感染。应进行肾脏和膀胱的超声检查以发现解剖异常。来自最近的 6 项研究的数据不支持使用抗菌预防来预防无膀胱输尿管反流(VUR)或 I 至 IV 级 VUR 的发热性复发性 UTI。因此,不建议在首次 UTI 后常规进行排尿性膀胱尿道造影(VCUG);如果肾脏和膀胱超声检查显示存在积水、瘢痕或其他表明高等级 VUR 或梗阻性尿路病的发现,或存在其他非典型或复杂的临床情况,则需要进行 VCUG;如果发生发热性 UTI 复发,也应进行 VCUG。本指南中的建议并非指示排他性治疗方案,也不作为护理标准;可能存在变化。关于抗菌预防和 VCUG 性能的建议是基于当前可用的证据。与所有美国儿科学会临床指南一样,建议将定期进行审查,并纳入新证据,例如来自随机干预儿童膀胱输尿管反流研究(RIVUR)的数据。
本次修订的变化包括 UTI 的诊断标准和影像学建议。